Drugs / CV787
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00116155 | — | prostate cancer | Cell Genesys | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CV787 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00116155 ↗ |
| Known as | CG7870 | “CV787 (CG7870)” NCT00116155 ↗ |
| Route | Intravenous | “Patients will receive treatment intravenously” NCT00116155 ↗ |